Chs Pharma Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for Chs Pharma Inc. Chs Pharma Inc has 1 trademark applications. The latest application filed is for "SULRX"
- Company Aliases
- CHS Pharma Inc.
- CHS Pharma Inc. - Naples FL US
- CHS Pharma, Inc. - Miami FL US
- CHS PHARMA, INC. - MIAMI FL US
Trademarks Patents
| Patent Application | Date |
|---|---|
| TREATMENT FOR ISCHEMIC STROKE 20210138021 - 17/149564 Wu; Jang-Yen | 2021-05-13 |
| GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF) GENE THERAPY FOR TREATING NEUROLOGICAL DISEASES 20210052745 - 17/089770 Wu; Jang-Yen | 2021-02-25 |
| Treatment for Ischemic Stroke 20190209512 - 16/357013 Wu; Jang-Yen ; et al. | 2019-07-11 |
| Treatment for Ischemic Stroke 20180055809 - 15/803280 Wu; Jang-Yen ; et al. | 2018-03-01 |
| USE OF SULINDAC FOR PROTECTING RETINAL PIGMENT EPITHELIAL CELLS AGAINST OXIDATIVE STRESS 20170143653 - 15/423227 Prentice; Howard M. ; et al. | 2017-05-25 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"SULRX" 85325639 |
SULRX 2011-05-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 